- Home
- VIVK vs ASBP Comparison
VIVK vs ASBP Comparison
Compare VIVK & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVK
- ASBP
- Stock Information
- Founded
- VIVK 2006
- ASBP 2021
- Country
- VIVK United States
- ASBP United States
- Employees
- VIVK N/A
- ASBP N/A
- Industry
- VIVK Oilfield Services/Equipment
- ASBP Biotechnology: Pharmaceutical Preparations
- Sector
- VIVK Energy
- ASBP Health Care
- Exchange
- VIVK Nasdaq
- ASBP Nasdaq
- Market Cap
- VIVK 20.9M
- ASBP 18.7M
- IPO Year
- VIVK N/A
- ASBP N/A
- Fundamental
- Price
- VIVK $0.29
- ASBP $0.32
- Analyst Decision
- VIVK
- ASBP
- Analyst Count
- VIVK 0
- ASBP 0
- Target Price
- VIVK N/A
- ASBP N/A
- AVG Volume (30 Days)
- VIVK 47.5M
- ASBP 40.8M
- Earning Date
- VIVK 11-18-2025
- ASBP 11-24-2025
- Dividend Yield
- VIVK N/A
- ASBP N/A
- EPS Growth
- VIVK N/A
- ASBP N/A
- EPS
- VIVK N/A
- ASBP N/A
- Revenue
- VIVK $124,048,464.00
- ASBP N/A
- Revenue This Year
- VIVK N/A
- ASBP N/A
- Revenue Next Year
- VIVK N/A
- ASBP N/A
- P/E Ratio
- VIVK N/A
- ASBP N/A
- Revenue Growth
- VIVK 98.83
- ASBP N/A
- 52 Week Low
- VIVK $0.18
- ASBP $0.20
- 52 Week High
- VIVK $1.68
- ASBP $15.80
- Technical
- Relative Strength Index (RSI)
- VIVK 40.79
- ASBP 42.71
- Support Level
- VIVK $0.18
- ASBP $0.30
- Resistance Level
- VIVK $0.25
- ASBP $0.37
- Average True Range (ATR)
- VIVK 0.09
- ASBP 0.07
- MACD
- VIVK 0.02
- ASBP 0.00
- Stochastic Oscillator
- VIVK 29.26
- ASBP 44.22
About VIVK Vivakor Inc.
Vivakor Inc is a socially responsible operator, acquirer and developer of technologies and assets in the oil and gas industry, as well as related environmental solutions. It is focused on operating crude oil gathering, storage and transportation facilities, as well as contaminated soil remediation services. Company have two operating business segments: Transportation logistics services; Terminaling and storage facility product and services related to oil and gas production. Majority of revenue is from Terminaling and storage segment.
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.